On March 3rd, HCmed hosted a lunch symposium at Chung Shan Medical University Hospital. During the event, we introduced our Pulmogine vibrating mesh nebulizer to pediatricians and nursing staff at the medical center.

HCmed is proud to announce that our Pulmogine Vibrating Mesh Nebulizer has been approved by the U.S. Food and Drug Administration (FDA) for use with Pulmozyme, a widely prescribed medication for cystic fibrosis patients.

As HCmed Innovations celebrates its 10th year in operation, our CEO, Jason Cheng, has unveiled a bold set of New Year resolutions aimed at propelling the organization to new heights.

We're excited to unveil our new HCmed UK site, located in Chichester, West Sussex UK.

HCmed announced the appointment of Gunilla Petersson, Ph.D. as the new Chief Scientific Officer (CSO).

Dr. Shao Chi Huang this month shares his experience working in the clinical field.

HCmed Innovations Co., Ltd. (6934) is pleased to announce that it has recently become a public company in Taiwan.

Chief Executive Officer (CEO) and founder of HCmed, Jason Cheng this week shares his experience founding and managing HCmed Innovations.

Finance and Accounting Manager of the Management Department at HCmed Innovations, Wooca Tu, this week shares his working experience and management goals at HCmed.